Aya M Almatary

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Molecular Docking

Metastatic Colorectal Cancer

Vascular Endothelial Growth Factor

Top Venues

Molecules (Basel, Switzerland)

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Aya M Almatary, Walaa M El Husseiny, Khalid B Selim, Hassan M H Eisa
Nitroimidazole derivatives potentiated against tumor hypoxia: Design, synthesis, antitumor activity, molecular docking study, and QSAR study. Drug development research (2023)